Ability of laboratories to detect emerging antimicrobial resistance in nosocomial pathogens: a survey of Project ICARE laboratories

Autor: Steward, C. D., Wallace, D., Hubert, S. K., Lawton, R., Fridkin, S. K., Gaynes, R. P., Jr, J. E. McGowan, Tenover, F. C.

Publikováno v: Diagnostic Microbiology and Infectious Disease; 2000, Vol. 38 Issue: 1 p59-67, 9p

Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996-1998.

Autor: Naimi TS; Acute Disease Epidemiology Section and the Division of Public Health Laboratories, Minnesota Department of Health, Minneapolis, USA. tbn7@cdc.gov, LeDell KH, Boxrud DJ, Groom AV, Steward CD, Johnson SK, Besser JM, O'Boyle C, Danila RN, Cheek JE, Osterholm MT, Moore KA, Smith KE

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2001 Oct 01; Vol. 33 (7), pp. 990-6. Date of Electronic Publication: 2001 Sep 05.

Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae.

Autor: Yigit H; Hospital Infections Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA., Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, Alberti S, Bush K, Tenover FC

Publikováno v: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2001 Apr; Vol. 45 (4), pp. 1151-61.

Comparison of agar dilution, disk diffusion, MicroScan, and Vitek antimicrobial susceptibility testing methods to broth microdilution for detection of fluoroquinolone-resistant isolates of the family Enterobacteriaceae.

Autor: Steward CD; Hospital Infections Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. cks7@cdc.gov, Stocker SA, Swenson JM, O'Hara CM, Edwards JR, Gaynes RP, McGowan JE Jr, Tenover FC

Publikováno v: Journal of clinical microbiology [J Clin Microbiol] 1999 Mar; Vol. 37 (3), pp. 544-7.

Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides.

Autor: Tenover FC; Hospital Infections Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. fnt1@CDC.GOV, Lancaster MV, Hill BC, Steward CD, Stocker SA, Hancock GA, O'Hara CM, McAllister SK, Clark NC, Hiramatsu K

Publikováno v: Journal of clinical microbiology [J Clin Microbiol] 1998 Apr; Vol. 36 (4), pp. 1020-7.